about
Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes.Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuriaA score test for association of a longitudinal marker and an event with missing dataA test for the relationship between a time-varying marker and both recovery and progression with missing data.High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-upSerum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetesRegression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetesHigh-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabeticsSerum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes.Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy.A Comparison of Clinical Parameters and Outcomes over 1 Year in Home Hemodialysis Patients Using 2008K@home or NxStage System One.A year-long quality improvement project on fluid management using blood volume monitoring during hemodialysis.Change in glycemic control predicts change in weight in adolescent boys with type 1 diabetes.Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide.Effects of dialysate to serum sodium (Na+) alignment in chronic hemodialysis (HD) patients: retrospective cohort study from a quality improvement project.Determinants of Progression from Microalbuminuria to Proteinuria in Patients Who Have Type 1 Diabetes and Are Treated with Angiotensin-Converting Enzyme InhibitorsMicroalbuminuria and the risk for early progressive renal function decline in type 1 diabetesEffects of Crit-Line® monitor use on patient outcomes and epoetin alfa dosing following onset of hemodialysis: a propensity score-matched studyReal-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data
P50
Q31112191-61257CBA-DF6A-4147-AB79-E5F44A74C998Q33488868-9E023282-C2F4-4386-A23D-BE5D8CC12A87Q33503383-C64C16AE-9000-4DA2-8EB4-D47465985407Q33843474-23E5B3AC-E336-460A-99FA-5E1452FB12A2Q33873169-30764DBF-0252-447C-83CC-E58B2A64348DQ34256592-52C596BF-6871-4559-A694-2C33A926949CQ34552269-7F12870B-ECA0-49ED-ABD1-03F4016A7A89Q35804154-9B7E00FB-C399-4511-99A0-894B029F98D9Q35817069-1C339CB2-B503-45BD-9CDF-F1B0BDB15194Q36662003-CC720C19-CFD2-4B22-8722-8B132BEF66B9Q36666878-A0B115EA-E4A1-46CD-96EE-56AF13DCE320Q37042111-BE8A2175-D42C-4426-8F93-F2B2FF65A0B5Q37051619-F6CD6EC6-1E77-4BDA-A646-397CA7604317Q37163742-75FF8757-0818-40C3-9A45-831BCF947991Q37291970-43930FE9-6FC4-46AA-A0A8-E88A390FC6C1Q40183043-3E15D25D-D010-4B6C-A24F-C93118AB2D89Q40975363-403776EB-DEBD-4E80-8702-5FE6CC17CDA8Q44718383-BA65EBC5-8D84-492E-98B4-8D1000B79B29Q51743408-E7C2E920-DDDE-4222-9D80-27E532904062Q52612541-78142FA8-E450-4E90-BC8E-BCF248239682Q57240448-A3761D08-5852-4497-8978-15D4A52A0CB3Q79848360-45A22019-BE0F-4A91-AF11-534506C77522Q88164816-77DD2384-1BFA-43A2-A882-B5F8727EEC07Q95529450-98FACCB6-4E69-43CE-BB7C-677AF2608B9F
P50
description
researcher, ORCID id # 0000-0003-3523-0028
@en
wetenschapper
@nl
name
Linda H Ficociello
@ast
Linda H Ficociello
@en
Linda H Ficociello
@es
Linda H Ficociello
@nl
type
label
Linda H Ficociello
@ast
Linda H Ficociello
@en
Linda H Ficociello
@es
Linda H Ficociello
@nl
prefLabel
Linda H Ficociello
@ast
Linda H Ficociello
@en
Linda H Ficociello
@es
Linda H Ficociello
@nl
P106
P1153
6507215810
P21
P31
P496
0000-0003-3523-0028